Bittner Sebastian, Ehrenschwender Martin
Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Germany.
FEBS Lett. 2017 Sep;591(17):2543-2555. doi: 10.1002/1873-3468.12747. Epub 2017 Jul 20.
Death Receptor 3 (DR3) and its cognate ligand TL1A belong to the tumor necrosis factor superfamily (TNFSF). This sophisticated network of receptor-ligand systems controls innumerable biological processes. For many (if not all) TNFSF ligands and receptors, a role in conditions such as inflammation, tissue development, proliferation, and cell death has been firmly established. However, relatively little is known about DR3 and TL1A. Here, we review novel aspects of DR3 signaling and DR3-associated signaling pathways before summarizing the function of DR3 in the immune system. The emerging role of DR3 in disease will be addressed before we finally critically discuss the potential therapeutic exploitation of this receptor-ligand pair.
死亡受体3(DR3)及其同源配体TL1A属于肿瘤坏死因子超家族(TNFSF)。这个复杂的受体-配体系统网络控制着无数的生物过程。对于许多(如果不是全部)TNFSF配体和受体而言,它们在炎症、组织发育、增殖和细胞死亡等病症中的作用已得到确凿证实。然而,人们对DR3和TL1A的了解相对较少。在此,我们在总结DR3在免疫系统中的功能之前,回顾DR3信号传导和DR3相关信号通路的新方面。在最终批判性地讨论这一受体-配体对的潜在治疗应用之前,将阐述DR3在疾病中的新作用。